US4490374A
Expired / Lapsed
US
⏱️ 0.0 years remaining
5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use
Assignee: Ortho Pharmaceutical Corp
•
Filing: 1982-09-30
•
Granted: 1984-12-25
•
Expires: 2002-09-30
Abstract
Abstract The synthesis of substituted quinazolinones is described. The novel quinazolinones are renal vasodilators and thereby increase renal blood flow, and are useful as cardiovascular agents.
Inventors
- 👤 Victor T. Bandurco
- 👤 Seymour D. Levine
- 👤 Dennis M. Mulvey
- 👤 Alfonso J. Tobia
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 13:27
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/06; A; A61; A61P; A61P13/00; A61P13/12; A61P9/00; A61P9/04; A61P9/08; A61P9/10; A61P9/12; C07C; C07C205/00; C07C205/44; C07C205/45; C07C265/00; C07C265/12; C07C309/00; C07D239/00; C07D239/70; C07D239/72; C07D239/78; C07D239/80; C07D317/00; C07D317/08; C07D317/10; C07D317/14; C07D317/18; C07D317/24; C07D317/26
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
70 words
A compound of the formula ##STR22## wherein R 2 is hydrogen, lower alkyl, cycloalkyl having 4-8 carbon atoms, cycloalkylalkyl wherein the cycloalkyl group has 4-8 carbon atoms and the alkyl group has 1-3 carbon atoms, haloalkyl having 1-3 halogen atoms and 1-4 carbon atoms, norbornyl and norbornylmethyl; R 6 is lower alkyl and R 7 is hydrogen, provided that R 7 is hydrogen only when the 3,4-imine linkage is saturated.
Claim 2
Dependent Claim
70 words
A compound of the formula ##STR22## wherein R 2 is hydrogen, lower alkyl, cycloalkyl having 4-8 carbon atoms, cycloalkylalkyl wherein the cycloalkyl group has 4-8 carbon atoms and the alkyl group has 1-3 carbon atoms, haloalkyl having 1-3 halogen atoms and 1-4 carbon atoms, norbornyl and norbornylmethyl; R 6 is lower alkyl and R 7 is hydrogen, provided that R 7 is hydrogen only when the 3,4-imine linkage is saturated.
Claim 3
Dependent Claim
8 words
A compound of claim 1 which is 5,6-dimethoxy-4-methyl-2(1H)quinazolinone.
Claim 4
Dependent Claim
8 words
A compound of claim 1 which is 3,4-dihydro-5,6-dimethoxy-4-methyl-2(1H)quinazolinone.
Claim 5
Dependent Claim
8 words
A compound of claim 1 which is 5,6-dimethoxy-2(1H)quinazolinone.
Claim 6
Dependent Claim
36 words
A pharmaceutical composition useful in the treatment of cardiovascular disorders in unit dosage form comprising from about 15 mg/kg to about 300 mg/kg of a compound of claim 1 in admixture with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim
30 words
The method of treating a patient having a cardiovascular disorder which comprises administering to said patient an effective amount of a compound of claim 1 in a pharmaceutically acceptable carrier.
References Cited (Backward Citations)
BE765947A
Cited
US3859237A
Cited
US3950526A
Cited
NL7209078A
Cited
JPS5217842A
Cited
GB2088874A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-12-25 | 1988-06-25 | 1988-12-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-12-25 | 1992-06-25 | 1992-12-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-12-25 | 1996-06-25 | 1996-12-25 | $7700.00 | Window Closed / Lapsed |